Core Points - The article outlines the investor relations management system of Ningbo Meinuo Pharmaceutical Co., Ltd, emphasizing the principles of fairness, openness, and integrity in communication with investors [1][2] - The company establishes a structured approach to investor reception and promotion, detailing the responsibilities of the board secretary and the securities affairs department [1][2] Group 1: General Principles - The company aims to enhance investor relations management and improve corporate governance by adhering to principles such as fairness, honesty, confidentiality, and efficiency [1][2] - The company prohibits unauthorized personnel from representing the company in investor relations activities, ensuring that only trained individuals participate [2] Group 2: Reception and Promotion Content - The company targets various stakeholders for its reception and promotion activities, including securities analysts, institutional investors, major shareholders, and media personnel [2][3] - Multiple communication channels are utilized, including the company website, stock exchange platforms, and investor education bases, to facilitate engagement with investors [3][4] Group 3: Communication and Disclosure - The company is committed to maintaining transparency by not disclosing any undisclosed significant information during communications with investors [4][5] - A detailed record-keeping system is established for all investor interactions, including the documentation of discussions and materials provided [5][6] Group 4: Compliance and Accountability - The company mandates that all investor-related activities be documented and that any violations of the established protocols will result in accountability for the involved parties [6][6] - The board of directors is responsible for interpreting the investor relations management system, which will take effect upon approval [6][6]
美诺华: 宁波美诺华药业股份有限公司接待和推广工作及信息披露备查登记制度